Stock market information for Humacyte Inc (HUMA)
- Humacyte Inc is a equity in the USA market.
- The price is 2.59 USD currently with a change of -0.04 USD (-0.02%) from the previous close.
- The latest open price was 2.66 USD and the intraday volume is 6643516.
- The intraday high is 2.925 USD and the intraday low is 2.58 USD.
- The latest trade time is Friday, June 6, 20:15:00 EDT.
---
๐ฌ *Whatโs Cooking at Humacyte?*
- *FDA Green Light*: Symvessโข, their bioengineered vascular graft, received FDA approval in December 2024.
- *Patent Power*: Secured a key patent for their Symvess manufacturing system, extending protection through 2040.
- *Kidney Collaboration*: Teamed up with Trestle Biotherapeutics to develop bioengineered kidneys, aiming to tackle the organ shortage crisis.
---
๐ *Price Predictions & Analyst Insights*
- *Short-Term Outlook*: Analysts have a consensus price target of 13.71, suggesting significant upside potential.
- *Long-Term Vision*: With the commercial launch of Symvess and ongoing collaborations, Humacyte is positioning itself as a leader in regenerative medicine.
โ
๐ง *Trade Setup Signal*
- *Support Level*:2.96 โ a potential buying opportunity if the price rebounds from this level.
- *Resistance Level*: $3.43 โ watch for a breakout above this to signal a bullish trend.
- *Volatility Alert*: High daily volatility (~7.68%) suggests potential for significant price swings.
---
๐ค *Final Thoughts*
Humacyte is making waves in the biotech world with its innovative tissue-engineered products. While the stock has experienced volatility, the company's advancements and strategic partnerships indicate a promising future. As always, conduct your own research and consider your risk tolerance before investing.